Metaplastic mammary carcinoma with discrepant hormone receptor results by IHC and RT-PCR.
نویسندگان
چکیده
This is a young premenopausal woman with a T1cN0 metaplastic breast cancer that is ER/PR Allred score 3, but negative by mRNA. Our recommendations are: adjuvant chemotherapy with TAC x 6 or dose-dense doxorubicin and cyclophosphamide followed by paclitaxel (ddAC-T). Whole-breast radiation therapy would follow. The patient could try tamoxifen, although the likelihood of benefit is very small.
منابع مشابه
Real-time RT-PCR: a complementary method to detect HER-2 status in breast carcinoma.
The option to treat patients presenting with HER-2 overexpressed invasive breast carcinoma with Herceptin requires quantitative determination of the HER-2 status. The aim of this study was to retrospectively evaluate the HER-2 mRNA expression levels using quantitative real-time RT-PCR (Q-RT-PCR) in tissue samples from 44 primary breast carcinomas and compare the results with immunohistochemistr...
متن کاملEarly Diagnosis of Breast Cancer using Molecular, Biochemical and Pathological Markers
Problem statement: Laboratory diagnosis of breast cancer in most of the hospitals has traditionally been performed using cell culture and the direct hormone receptor assay, which are money and time consuming. Approach: This study was performed in order to direct the attention toward increasing the efficiency of early diagnosis in clinical laboratories at the western region of KSA and Egypt usin...
متن کاملEstrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
PURPOSE Central and local laboratory concordance for hormone receptor measurement is therapeutically important. This study compares estrogen receptor (ER) and progesterone receptor (PR) measured by local laboratory immunohistochemistry (IHC), central IHC, and central reverse-transcriptase polymerase chain reaction (RT-PCR) using a proprietary 21-gene assay. PATIENTS AND METHODS A case-control...
متن کاملProblems and solutions in the evaluation of hormone receptors in breast cancer.
An article by Badve et al in this issue of the Journal of Clinical Oncology describes an interesting study comparing two methods of assessing estrogen-receptor (ER) and progesterone-receptor (PR) expression in invasive breast cancer (IBC). One method measured protein by immunohistochemistry (IHC) and the other measured RNA using quantitative reverse-transcription polymerase chain reaction (RT-P...
متن کاملRelevance of progesterone receptor immunohistochemical staining to Oncotype DX recurrence score.
OBJECTIVE/BACKGROUND Progesterone-receptor negativity (PR-) is predictive of adverse outcomes in estrogen receptor-positive (ER+) breast cancer. The Oncotype DX assay provides risk stratification for hormone receptor-positive (HR+) invasive breast cancer; however, the association of PR status and Oncotype DX recurrence scores (RSs) is less clear. METHODS We designed an analysis to determine w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Oncology
دوره 27 6 شماره
صفحات -
تاریخ انتشار 2013